TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -76.95%-82.61M | ---- | 85.91%-46.69M | ---- | -11.03%-331.36M | ---- | -7,247.14%-298.44M | ---- | -104.86%-4.06M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 50.71%-1.52M | ---- | 41.04%-3.09M | ---- | 41.96%-5.24M | ---- | 59.06%-9.03M | ---- | 22.13%-22.05M |
Attributable subsidiary (profit) loss | ---- | -110.16%-2.32M | ---- | -55.04%22.79M | ---- | 30.40%50.68M | ---- | 258.28%38.87M | ---- | 31.47%-24.56M |
Impairment and provisions: | ---- | 1,528.71%18.1M | ---- | -99.20%1.11M | ---- | 92.33%138.27M | ---- | 8,831.18%71.9M | ---- | -61.09%805K |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | 31.60%49.24M | ---- | --37.42M | ---- | ---- |
-Other impairments and provisions | ---- | 1,528.71%18.1M | ---- | -98.75%1.11M | ---- | 158.22%89.04M | ---- | 4,183.23%34.48M | ---- | -61.09%805K |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -27.78%6.5M | ---- | --9M |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -27.78%6.5M | ---- | --9M |
Asset sale loss (gain): | ---- | 100.46%256K | ---- | -27,425.12%-55.88M | ---- | -124.43%-203K | ---- | -18.77%831K | ---- | 668.33%1.02M |
-Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---56.01M | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 86.86%256K | ---- | 167.49%137K | ---- | -124.43%-203K | ---- | -18.77%831K | ---- | 668.33%1.02M |
Depreciation and amortization: | ---- | 20.39%188.52M | ---- | -6.15%156.59M | ---- | -15.45%166.85M | ---- | -5.61%197.33M | ---- | 172.66%209.06M |
-Amortization of intangible assets | ---- | 837.25%6.95M | ---- | -49.97%741K | ---- | 0.00%1.48M | ---- | -0.07%1.48M | ---- | 0.00%1.48M |
Financial expense | ---- | -7.42%39.36M | ---- | -30.36%42.52M | ---- | -16.30%61.06M | ---- | -12.27%72.95M | ---- | 60.21%83.15M |
Exchange Loss (gain) | ---- | -79.93%8.97M | ---- | 428.65%44.7M | ---- | 36.55%-13.6M | ---- | -213.19%-21.44M | ---- | -129.06%-6.85M |
Special items | ---- | -98.94%-27.3M | ---- | 3.94%-13.73M | ---- | 76.61%-14.29M | ---- | ---61.08M | ---- | ---- |
Operating profit before the change of operating capital | ---- | -4.64%141.46M | ---- | 184.33%148.33M | ---- | 3,332.28%52.17M | ---- | -100.66%-1.61M | ---- | 41.49%245.52M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -108.46%-2.56M | ---- | -301.31%-1.23M | ---- | 15.94%611K | ---- | 138.72%527K | ---- | -1,206.50%-1.36M |
Accounts receivable (increase)decrease | ---- | 2.05%13.91M | ---- | -63.22%13.63M | ---- | -38.58%37.06M | ---- | 310.36%60.33M | ---- | 55.45%-28.68M |
Accounts payable increase (decrease) | ---- | 215.85%18.3M | ---- | -143.77%-15.79M | ---- | 122.95%36.08M | ---- | -580.16%-157.2M | ---- | 772.24%32.74M |
Special items for working capital changes | -4.79%-14.32M | 158.23%9.58M | ---13.67M | -7.38%-16.45M | ---- | 40.24%-15.32M | ---- | -649.28%-25.64M | ---- | 122.79%4.67M |
Cash from business operations | -4.79%-14.32M | 40.62%180.68M | ---13.67M | 16.17%128.49M | ---- | 189.49%110.6M | ---- | -148.87%-123.58M | ---- | 201.34%252.88M |
Other taxs | ---- | -501.75%-5.83M | ---- | 89.70%-969K | ---- | 60.03%-9.41M | ---- | 30.28%-23.54M | ---- | 12.40%-33.77M |
Interest received - operating | ---- | -50.06%1.59M | ---- | -39.45%3.17M | ---- | -58.67%5.24M | ---- | -31.24%12.68M | ---- | -34.61%18.45M |
Special items of business | 37.56%110.54M | -23.73%-30.7M | 52.89%80.36M | -21.90%-24.81M | 313.64%52.56M | 65.37%-20.35M | 82.42%-24.6M | -32.42%-58.77M | -1,140.43%-139.98M | 32.82%-44.38M |
Net cash from operations | 44.27%96.22M | 37.64%145.74M | 26.89%66.7M | 23.01%105.89M | 313.64%52.56M | 144.55%86.08M | 82.42%-24.6M | -200.02%-193.21M | -1,140.43%-139.98M | 2,473.99%193.18M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | --28.93M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.82%31.96M |
Loan receivable (increase) decrease | ---- | -56.38%400K | ---- | 203.73%917K | ---- | -109.50%-884K | ---- | 197.11%9.31M | ---- | -1,066.90%-9.58M |
Decrease in deposits (increase) | 111.33%2.85M | -165.57%-27.6M | ---25.12M | 135.79%42.09M | ---- | -74.19%17.85M | ---- | --69.15M | --87M | ---- |
Sale of fixed assets | ---- | ---- | ---- | -99.68%1K | ---- | 110.81%312K | ---- | -83.35%148K | ---- | 69.33%889K |
Purchase of fixed assets | 89.45%-5.85M | -12.33%-86.81M | -61.67%-55.43M | 38.16%-77.28M | -7.23%-34.29M | -249.69%-124.97M | -84.15%-31.98M | 36.87%-35.74M | 51.17%-17.36M | 40.81%-56.61M |
Purchase of intangible assets | ---3.32M | ---30.04M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | --294.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | --216.87M | --217.4M | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | ---18.54M | ---- | ---- | ---- | ---- | ---- | ---- |
Other items in the investment business | ---- | ---- | 104.80%350K | ---- | -7,494.79%-7.29M | ---- | -101.01%-96K | ---- | 205.84%9.53M | ---- |
Net cash from investment operations | 458.99%287.92M | -170.17%-115.12M | -145.62%-80.2M | 252.33%164.06M | 648.23%175.82M | -351.24%-107.7M | -140.51%-32.07M | 228.57%42.87M | 728.49%79.17M | -171.74%-33.34M |
Net cash before financing | 2,943.83%384.15M | -88.66%30.62M | -105.91%-13.51M | 1,348.92%269.94M | 502.98%228.39M | 85.62%-21.61M | 6.81%-56.67M | -194.06%-150.35M | -7,187.88%-60.81M | 196.12%159.84M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -99.35%3.33M | ---- | --513.6M | ---- | ---- | ---- | --1.25B | --1.24B | ---- |
Refund | -99.46%-51.58M | 92.70%-77.52M | 91.26%-25.86M | -582.76%-1.06B | -262.48%-296M | 85.71%-155.48M | 92.09%-81.66M | -332.77%-1.09B | -721.83%-1.03B | 36.94%-251.39M |
Interest paid - financing | 6.20%-9.05M | 16.60%-19.43M | 21.61%-9.65M | 8.43%-23.29M | 0.43%-12.31M | 23.31%-25.44M | 26.45%-12.36M | 4.57%-33.17M | 2.62%-16.81M | ---34.76M |
Net cash from financing operations | -37.75%-117.32M | 71.76%-190.71M | 75.11%-85.17M | -151.91%-675.26M | -149.62%-342.11M | -594.40%-268.06M | -182.31%-137.05M | 114.29%54.22M | 190.10%166.51M | 41.52%-379.4M |
Effect of rate | -391.17%-2.61M | 120.11%1.31M | 92.60%-532K | -1,189.48%-6.5M | -260.73%-7.19M | -103.76%-504K | 80.69%-1.99M | 689.20%13.42M | -920.25%-10.33M | 85.95%-2.28M |
Net Cash | 370.41%266.83M | 60.50%-160.09M | 13.23%-98.68M | -39.92%-405.32M | 41.30%-113.73M | -201.33%-289.67M | -283.28%-193.72M | 56.22%-96.13M | 157.46%105.7M | 63.09%-219.56M |
Begining period cash | -56.00%124.77M | -59.22%283.55M | -59.22%283.55M | -29.44%695.37M | -29.44%695.37M | -7.74%985.55M | -7.74%985.55M | -17.20%1.07B | -17.20%1.07B | -32.14%1.29B |
Cash at the end | 111.01%388.99M | -56.00%124.77M | -67.91%184.35M | -59.22%283.55M | -27.27%574.45M | -29.44%695.37M | -32.12%789.83M | -7.74%985.55M | 5.08%1.16B | -17.20%1.07B |
Cash balance analysis | ||||||||||
Bank deposits | ---- | ---- | ---- | ---- | -11.04%178.81M | ---- | -57.77%201M | ---- | -15.30%475.91M | ---- |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | -11.04%178.81M | ---- | -57.77%201M | ---- | -15.30%475.91M | ---- |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.